IMD INTERNATIONAL MEDICAL DE (IMD.MI) Stock Fundamental Analysis

BIT:IMD • IT0005549255

1.35 EUR
-0.03 (-2.17%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall IMD gets a fundamental rating of 5 out of 10. We evaluated IMD against 65 industry peers in the Health Care Equipment & Supplies industry. IMD has a great financial health rating, but its profitability evaluates not so good. IMD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • IMD had positive earnings in the past year.
  • IMD had a positive operating cash flow in the past year.
IMD.MI Yearly Net Income VS EBIT VS OCF VS FCFIMD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

  • IMD's Return On Assets of 4.04% is in line compared to the rest of the industry. IMD outperforms 60.00% of its industry peers.
  • The Return On Equity of IMD (6.09%) is comparable to the rest of the industry.
  • IMD's Return On Invested Capital of 4.85% is on the low side compared to the rest of the industry. IMD is outperformed by 61.54% of its industry peers.
  • IMD had an Average Return On Invested Capital over the past 3 years of 12.28%. This is above the industry average of 9.73%.
  • The last Return On Invested Capital (4.85%) for IMD is well below the 3 year average (12.28%), which needs to be investigated, but indicates that IMD had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.04%
ROE 6.09%
ROIC 4.85%
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
IMD.MI Yearly ROA, ROE, ROICIMD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

  • IMD's Profit Margin of 3.70% is in line compared to the rest of the industry. IMD outperforms 43.08% of its industry peers.
  • In the last couple of years the Profit Margin of IMD has declined.
  • The Operating Margin of IMD (4.83%) is worse than 64.62% of its industry peers.
  • IMD's Operating Margin has declined in the last couple of years.
  • IMD has a worse Gross Margin (24.88%) than 89.23% of its industry peers.
  • IMD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.83%
PM (TTM) 3.7%
GM 24.88%
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
IMD.MI Yearly Profit, Operating, Gross MarginsIMD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • IMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for IMD remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for IMD has been reduced compared to a year ago.
IMD.MI Yearly Shares OutstandingIMD.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
IMD.MI Yearly Total Debt VS Total AssetsIMD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 3.90 indicates that IMD is not in any danger for bankruptcy at the moment.
  • IMD has a Altman-Z score of 3.90. This is in the better half of the industry: IMD outperforms 67.69% of its industry peers.
  • The Debt to FCF ratio of IMD is 0.19, which is an excellent value as it means it would take IMD, only 0.19 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.19, IMD belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that IMD is not too dependend on debt financing.
  • IMD's Debt to Equity ratio of 0.01 is amongst the best of the industry. IMD outperforms 89.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Altman-Z 3.9
ROIC/WACC0.61
WACC7.93%
IMD.MI Yearly LT Debt VS Equity VS FCFIMD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • IMD has a Current Ratio of 3.53. This indicates that IMD is financially healthy and has no problem in meeting its short term obligations.
  • IMD's Current ratio of 3.53 is amongst the best of the industry. IMD outperforms 90.77% of its industry peers.
  • IMD has a Quick Ratio of 1.74. This is a normal value and indicates that IMD is financially healthy and should not expect problems in meeting its short term obligations.
  • IMD has a Quick ratio of 1.74. This is in the better half of the industry: IMD outperforms 75.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.53
Quick Ratio 1.74
IMD.MI Yearly Current Assets VS Current LiabilitesIMD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • IMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.43%.
  • IMD shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.97% yearly.
  • IMD shows a decrease in Revenue. In the last year, the revenue decreased by -5.61%.
  • The Revenue has been decreasing by -5.22% on average over the past years.
EPS 1Y (TTM)-48.43%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%-66.28%
Revenue 1Y (TTM)-5.61%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%-15.36%

3.2 Future

  • IMD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.27% yearly.
  • Based on estimates for the next years, IMD will show a small growth in Revenue. The Revenue will grow by 1.81% on average per year.
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMD.MI Yearly Revenue VS EstimatesIMD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
IMD.MI Yearly EPS VS EstimatesIMD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.05 0.1 0.15 0.2

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.88, the valuation of IMD can be described as correct.
  • Based on the Price/Earnings ratio, IMD is valued cheaper than 86.15% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.64. IMD is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 9.55, which indicates a very decent valuation of IMD.
  • Based on the Price/Forward Earnings ratio, IMD is valued cheaper than 92.31% of the companies in the same industry.
  • IMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.88
Fwd PE 9.55
IMD.MI Price Earnings VS Forward Price EarningsIMD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMD is valued cheaper than 87.69% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IMD is valued cheaper than 93.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.64
EV/EBITDA 7.7
IMD.MI Per share dataIMD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • A cheap valuation may be justified as IMD's earnings are expected to decrease with -6.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.46%, IMD is a good candidate for dividend investing.
  • IMD's Dividend Yield is rather good when compared to the industry average which is at 1.14. IMD pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, IMD pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.46%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 212.93% of the earnings are spent on dividend by IMD. This is not a sustainable payout ratio.
DP212.93%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
IMD.MI Yearly Income VS Free CF VS DividendIMD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 2M -2M 4M -4M 6M
IMD.MI Dividend Payout.IMD.MI Dividend Payout, showing the Payout Ratio.IMD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IMD INTERNATIONAL MEDICAL DE

BIT:IMD (2/18/2026, 7:00:00 PM)

1.35

-0.03 (-2.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.87%
Inst Owner ChangeN/A
Ins Owners75.51%
Ins Owner ChangeN/A
Market Cap23.83M
Revenue(TTM)36.29M
Net Income(TTM)1.34M
Analysts45.71
Price Target1.53 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.46%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP212.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.88
Fwd PE 9.55
P/S 0.66
P/FCF 10.64
P/OCF 8.19
P/B 1.08
P/tB 1.15
EV/EBITDA 7.7
EPS(TTM)0.08
EY5.93%
EPS(NY)0.14
Fwd EY10.47%
FCF(TTM)0.13
FCFY9.4%
OCF(TTM)0.16
OCFY12.22%
SpS2.06
BVpS1.25
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.5
Profitability
Industry RankSector Rank
ROA 4.04%
ROE 6.09%
ROCE 7.08%
ROIC 4.85%
ROICexc 6.32%
ROICexgc 6.81%
OM 4.83%
PM (TTM) 3.7%
GM 24.88%
FCFM 6.17%
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
ROICexc(3y)15.57%
ROICexc(5y)N/A
ROICexgc(3y)16.37%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexgc growth 3Y-23.19%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.4%
ROICexc growth 5YN/A
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Debt/EBITDA 0.1
Cap/Depr 104.88%
Cap/Sales 1.85%
Interest Coverage 250
Cash Conversion 121.64%
Profit Quality 167.02%
Current Ratio 3.53
Quick Ratio 1.74
Altman-Z 3.9
F-Score6
WACC7.93%
ROIC/WACC0.61
Cap/Depr(3y)149.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.43%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%-66.28%
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.61%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%-15.36%
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A
EBIT growth 1Y-52.97%
EBIT growth 3Y-19.48%
EBIT growth 5YN/A
EBIT Next Year-3.63%
EBIT Next 3Y-1.22%
EBIT Next 5YN/A
FCF growth 1Y354.49%
FCF growth 3Y32.27%
FCF growth 5YN/A
OCF growth 1Y712.77%
OCF growth 3Y35.57%
OCF growth 5YN/A

IMD INTERNATIONAL MEDICAL DE / IMD.MI FAQ

What is the ChartMill fundamental rating of IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to IMD.MI.


What is the valuation status for IMD stock?

ChartMill assigns a valuation rating of 6 / 10 to IMD INTERNATIONAL MEDICAL DE (IMD.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for IMD INTERNATIONAL MEDICAL DE?

IMD INTERNATIONAL MEDICAL DE (IMD.MI) has a profitability rating of 2 / 10.


What is the financial health of IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?

The financial health rating of IMD INTERNATIONAL MEDICAL DE (IMD.MI) is 8 / 10.


What is the expected EPS growth for IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?

The Earnings per Share (EPS) of IMD INTERNATIONAL MEDICAL DE (IMD.MI) is expected to decline by -23.53% in the next year.